Logo-apb
Adv Pharm Bull. 2020;10(1): 39-45. doi: 10.15171/apb.2020.005
PMID: 32002360        PMCID: PMC6983993

Research Article

Development and Characterization of Nanoliposomal Hydroxyurea Against BT-474 Breast Cancer Cells

Azam Akbari 1,2 ORCID, Azim Akbarzadeh 2 * ORCID, Morteza Rafiee Tehrani 1, Reza Ahangari Cohan 2 ORCID, Mohsen Chiani 2, Mohammad Reza Mehrabi 2

Cited by CrossRef: 15


1- Tabandeh Z, Reisi-Vanani A. Investigation of the adsorption behavior of two anticancer drugs on the pristine and BN-doped graphdiyne nanosheet: A DFT-D3 perception. Diamond and Related Materials. 2021;119:108564 [Crossref]
2- Rethi L, Mutalik C, Anurogo D, Lu L, Chu H, Yougbaré S, Kuo T, Cheng T, Chen F. Lipid-Based Nanomaterials for Drug Delivery Systems in Breast Cancer Therapy. Nanomaterials. 2022;12(17):2948 [Crossref]
3- Saadh M, Mirzaei M, Dhiaa S, Rokni Hosseini L, Kushakova G, Da'i M, Salem-Bekhit M. Density functional theory assessments of an iron-doped graphene platform towards the hydrea anticancer drug delivery. Diamond and Related Materials. 2024;141:110683 [Crossref]
4- Tazhbayev Y, Mukashev O, Burkeyev M, Lozinsky V. Synthesis and Comparative Study of Nanoparticles Derived from Bovine and Human Serum Albumins. Polymers. 2020;12(6):1301 [Crossref]
5- Cai H, Chen L, Yang S, Jiang R, Guo Y, He M, Luo Y, Hong G, Li H, Song K. Personalized differential expression analysis in triple-negative breast cancer. 2024;23(4):495 [Crossref]
6- Rajendra P, Nidamanuri B, Swaroop A, Krishnamurali J, Balan A, Selvaraj J, Raman R, Shivakumar H, Reddy M, Jawahar N. Fabrication and in vitro evaluation of silk fibroin-folic acid decorated paclitaxel and hydroxyurea nanostructured lipid carriers for targeting ovarian cancer cells: A double sword approach. Journal of Drug Delivery Science and Technology. 2023;81:104270 [Crossref]
7- Khanuja H, Dureja H. Recent Patents and Potential Applications of Homogenisation Techniques in Drug Delivery Systems. NANOTEC. 2023;17(1):33 [Crossref]
8- Balicki M, Śmiechowski M. Hydration of N-Hydroxyurea from Ab Initio Molecular Dynamics Simulations. Molecules. 2024;29(11):2435 [Crossref]
9- Parsaee S, Jahani N, Salehiniya H, Raeison M. Effectiveness of Mindfulness Training in Emotion Regulation and Distress Tolerance among Breast Cancer Patients. ijbd. 2024;17(1):84 [Crossref]
10- Najmafshar A, Rostami M, Varshosaz J, Norouzian D, Samsam Shariat S. Enhanced antitumor activity of bovine lactoferrin through immobilization onto functionalized nano graphene oxide: an in vitro / in vivo study . Drug Delivery. 2020;27(1):1236 [Crossref]
11- Witt B, Tollefsbol T. Molecular, Cellular, and Technical Aspects of Breast Cancer Cell Lines as a Foundational Tool in Cancer Research. Life. 2023;13(12):2311 [Crossref]
12- noruzpuor M, Asghari Zakaria R, Zare N, Ebrahimi H, Parsa H, Bourang S. Investigating the Anticancer Properties of the Essential Oil and Aqueous Extract of Moringa oleifera and its Biosynthesized Metal Nanoparticles on MCF-7 and BT-549 Cell Lines. ijbd. 2024;17(1):59 [Crossref]
13- Chaghervand M, Torbati M, Shaabanzadeh M, Ahmadi A, Tafvizi F. Hydroxyurea-loaded Fe3O4/SiO2/chitosan-g-mPEG2000 nanoparticles; pH-dependent drug release and evaluation of cell cycle arrest and altering p53 and lincRNA-p21 genes expression. Naunyn-Schmiedeberg's Arch Pharmacol. 2022;395(1):51 [Crossref]
14- Mallick A, Sahu R, Nandi G, Dua T, Shaw T, Dhar A, Kanu A, Paul P. Development of Liposomal Formulation for Controlled Delivery of Valacyclovir: an In Vitro Study. J Pharm Innov. 2023;18(3):1020 [Crossref]